Sun Pharmaceutical Industries Limited announced that US FDA conducted an inspection at Company's Dadra facility from December 4, 2023 to December 15, 2023. US FDA has subsequently determined that the inspection classification status of this facility as Official Action Indicated (OAI).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,513 INR | +0.41% | +4.13% | +20.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.14% | 43.3B | |
+23.67% | 22.22B | |
+15.71% | 15.43B | |
+23.10% | 14.48B | |
+57.58% | 12.72B | |
-0.05% | 6.79B | |
-10.69% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B | |
+8.29% | 4.78B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- US FDA Determines Inspection Classification Status of the Dadra Facility as Official Action Indicated of Sun Pharmaceutical Industries Limited